Analyzing competing risks in the treatment of lung cancer: a good start

Jae Y Kim¹

Affiliations

Editorial

Jae Y Kim. J Thorac Dis. 2017 Mar.

. 2017 Mar;9(3):474-476.

doi: 10.21037/jtd.2017.02.96.

Jae Y Kim¹

¹ Department of Surgery, Division of Thoracic Surgery, City of Hope, Duarte, CA, USA.

No abstract available

Conflict of interest statement

Conflict of Interest: The author has no conflicts of interest to declare.

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
Eguchi T, Bains S, Lee MC, Tan KS, Hristov B, Buitrago DH, Bains MS, Downey RJ, Huang J, Isbell JM, Park BJ, Rusch VW, Jones DR, Adusumilli PS. Eguchi T, et al. J Clin Oncol. 2017 Jan 20;35(3):281-290. doi: 10.1200/JCO.2016.69.0834. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 28095268 Free PMC article.

1. Moyer VA, U.S. Preventive Services Task Force Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8. - PubMed
1. Institute of Medicine (U.S.). Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001:337.
1. Eguchi T, Bains S, Lee MC, et al. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis. J Clin Oncol 2017;35:281-90. 10.1200/JCO.2016.69.0834 - DOI - PMC - PubMed
1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975-2013. National Cancer Institute; 2015.
1. Raz DJ, Wu GX, Consunji M, et al. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians. J Thorac Oncol 2016;11:1856-62. 10.1016/j.jtho.2016.06.010 - DOI - PMC - PubMed